|
ZNF41 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.56819999999858E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.340060E-02 |
| Normal-vs-Stage2 |
5.782400E-02 |
| Normal-vs-Stage3 |
1.86681999999605E-05 |
| Normal-vs-Stage4 |
2.91829999998772E-06 |
| Stage1-vs-Stage2 |
7.077600E-01 |
| Stage1-vs-Stage3 |
5.959800E-03 |
| Stage1-vs-Stage4 |
1.519260E-03 |
| Stage2-vs-Stage3 |
1.333160E-01 |
| Stage2-vs-Stage4 |
5.893800E-02 |
| Stage3-vs-Stage4 |
4.292000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.223800E-04 |
| Normal-vs-AfricanAmerican |
3.57220000000158E-05 |
| Normal-vs-Asian |
8.570400E-01 |
| Caucasian-vs-AfricanAmerican |
5.276100E-02 |
| Caucasian-vs-Asian |
2.078400E-01 |
| AfricanAmerican-vs-Asian |
5.692000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.005900E-04 |
| Normal-vs-Female |
5.639000E-04 |
| Male-vs-Female |
9.953000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.510400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.861000E-03 |
| Normal-vs-Age(61-80Yrs) |
8.47950000000264E-05 |
| Normal-vs-Age(81-100Yrs) |
7.591800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.005400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.947000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.816400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.040430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.512230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.458800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.115700E-02 |
| Normal-vs-Grade 2 |
2.302100E-02 |
| Normal-vs-Grade 3 |
3.7079000000384E-06 |
| Normal-vs-Grade 4 |
1.61109999996523E-06 |
| Grade 1-vs-Grade 2 |
1.848120E-02 |
| Grade 1-vs-Grade 3 |
1.442860E-04 |
| Grade 1-vs-Grade 4 |
2.596200E-04 |
| Grade 2-vs-Grade 3 |
2.964500E-03 |
| Grade 2-vs-Grade 4 |
7.584100E-04 |
| Grade 3-vs-Grade 4 |
1.246200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.918200E-02 |
| Normal-vs-ccB subtype |
1.163740E-03 |
| ccA subtype-vs-ccB subtype |
6.651700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.421380E-03 |
| Normal-vs-N1 |
9.750600E-04 |
| N0-vs-N1 |
1.330760E-01 |
|
|
